Synthetic vaccine particles for durable cytolytic T lymphocyte responses and anti-tumor immunotherapy.

Autor: Ilyinskii, Petr O.1, Kovalev, Grigoriy I.2, O’Neil, Conlin P.1, Roy, Christopher J.1, Michaud, Alicia M.1, Drefs, Natalia M.2, Pechenkin, Mikhail A.2, Fu, Fen-ni1, Johnston, Lloyd P. M.1, Ovchinnikov, Dmitry A.2, Kishimoto, Takashi Kei1 kkishimoto@selectabio.com
Zdroj: PLoS ONE. 1/6/2018, Vol. 13 Issue 5, p1-20. 20p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje